Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

28
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ALLERGAN, INC.
1d ago ALLERGAN : Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acqui..
1d ago ALLERGAN : Patent Application Titled "Topical Treatment for Chemotherapy Induced..
1d ago ALLERGAN : Other Events (form 8-K)
2d ago ALLERGAN : 2Q profit climbs 16 percent
2d ago ALLERGAN : Syntaxin Assigned Patent
2d ago ALLERGAN : cuts jobs, lifts profit
2d ago ALLERGAN : cuts jobs, lifts profit
2d ago ALLERGAN : cuts jobs, lifts profit
2d ago ALLERGAN : slashes its workforce
3d agoDJAllergan to Lay Off 13% of Workforce, Cut Drug Research -- 3rd Update
3d ago ALLERGAN : Valeant contacts regulators about what it says are misleading claims ..
3d ago ALLERGAN : Valeant complains about Allergan to U.S., Canadian regulators
3d ago ALLERGAN : Results of Operations and Financial Condition, Other Events, Financia..
3d ago ALLERGAN : to cut 1,500 employees in restructuring
3d agoDJU.S. HOT STOCK FUTURES : Hot Stocks to Watch
3d ago ALLERGAN : Reports Second Quarter 2014 Operating Results
3d agoDJValeant Pharmaceuticals Complains to SEC Over Allergan Claims -CNBC
6d ago ALLERGAN : Announces Quarterly Conference Call
7d ago ALLERGAN : rules on shareholder meetings onerous (Ackman)
07/16 CARL ICAHN : Icahn and Ackman, foes on Herbalife, make up at conference
07/16 ALLERGAN : Patent Issued for Prostaglandin and Prostamide Drug Delivery Systems ..
07/16 ALLERGAN : Patent Application Titled "Topical Treatment for Chemotherapy Induced..
07/16 ALLERGAN : Patent Application Titled "Crystalline Forms of Bimatoprost Acid, Met..
07/16 ALLERGAN : "Tromethamine Salt of Bimatoprost Acid in Crystalline Form, Methods f..
07/16 ALLERGAN : Ackman urges Allergan talks with Valeant, no delay to special meeting
07/16 ALLERGAN : Pershing Square Releases Letter to Allergan’s Board of Director..
07/15 ALLERGAN : Assigned Patent
07/14DJU.S. HOT STOCKS : Hot Stocks to Watch
07/14 ALLERGAN : Files Investor Presentation
07/14 ALLERGAN : Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acqui..
07/14 ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
07/11 WILLIAM ACKMAN : Allergan asks stockholders not to act on Pershing Square propos..
07/11 ALLERGAN : Comments on Pershing Square’s Definitive Proxy Solicitation
07/10DJU.S. HOT STOCKS : Hot Stocks to Watch
07/09 ALLERGAN : Patent Issued for Inductively Powered Remotely Adjustable Gastric Ban..
07/09 ALLERGAN : New Toxicology and Applied Pharmacology Findings from Allergan Discus..
07/07 ALLERGAN : Pershing Square offers slate for Allergan board
07/07 ALLERGAN : Pershing Square names Allergan board candidates
07/07 ALLERGAN : Pershing files documents for special meeting aimed at ousting Allerga..
07/07DJPershing Proposes Six Directors for Allergan Board
07/07 ALLERGAN : Pershing Square Proposes Independent Slate For Allergan Board of Dire..
07/02 ALLERGAN : Patent Issued for Source Reservoir with Potential Energy for Remotely..
07/02 ALLERGAN : Board of Directors Unanimously Rejects Unsolicited Exchange Offer fro..
07/02 ALLERGAN : Valeant Posts Fact-Based Answers To Refute Allergan's Misleading Stat..
07/02 ALLERGAN : Patent Issued for Topical Treatment for Chemotherapy Induced Eyelash ..
07/02 ALLERGAN : Announces R%7ED Pipeline Update and U.S. FDA Approval; Company to Hos..
07/01 ALLERGAN : Investor Ackman hires Credit Suisse for Allergan bid -source
07/01 WILLIAM ACKMAN : Investor Ackman hires Credit Suisse for Allergan bid
07/01 Allergan readies defense as it fights Valeant for votes
07/01DJPershing Square Hires Credit Suisse as Banker in Allergan Campaign -- Update
07/01 Sanofi raises stake in Regeneron; shares jump
07/01 ALLERGAN : Assigned Patent
06/30 ALLERGAN : Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host ..
06/30 ALLERGAN : Other Events, Financial Statements and Exhibits (form 8-K)
06/30 Global M&A at seven-year high as big corporate deals return
06/27 ALLERGAN : Other Events (form 8-K)
06/27 WILLIAM ACKMAN : Allergan, Ackman agree special meeting won't trigger poison pil..
06/27 ALLERGAN : Pershing Square and Allergan Settle Delaware Court of Chancery Lawsui..
06/26 ALLERGAN : Valeant CEO 'delighted' by Paulson's Allergan stake
06/26 ALLERGAN : Senators Call on FTC, DOJ to Review Potential Valeant, Allergan Merge..
06/26 ALLERGAN : Valeant Commences Exchange Offer For Allergan
06/26 ALLERGAN : Board Unanimously Rejects Valeant's Unsolicited Exchange Offer
06/26 ALLERGAN : Board of Directors Reports on Unsolicited Exchange Offer from Valeant
06/25 JOHN PAULSON : Paulson & Co amasses large stake in Allergan: sources
06/25 ALLERGAN : If Bill Ackman's Co-Conspirator Can Muster 25% Of Allergan Shareholde..
06/25 ALLERGAN : Valeant calls its shareholders to a special meeting
06/24 ALLERGAN : tells investors to shun Valeant's $52bn takeover offer
06/23 ALLERGAN : plans to raise earnings outlook -CEO
06/23 Shire flags new drugs in AstraZeneca-style defence to AbbVie
06/23 Allergan advises shareholders against Valeant tender offer
06/23 ALLERGAN : tells shareholders to reject Valeant deal
06/23 ALLERGAN : urges shareholders to reject Valeant Pharmaceuticals takeover offer
06/23 ALLERGAN : Board of Directors Unanimously Rejects Unsolicited Exchange Offer fro..
06/23 ALLERGAN : Board of Directors Updates on Unsolicited Exchange Offer from Valeant
06/20 Shire rejects AbbVie's $46 billion takeover bid
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
Allergan, Inc. : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF